Protective and opsonic activities of a native, pH 4.25 intravenous immunoglobulin G preparation against common bacterial pathogens
- PMID: 3092306
- DOI: 10.1093/clinids/8.supplement_4.s396
Protective and opsonic activities of a native, pH 4.25 intravenous immunoglobulin G preparation against common bacterial pathogens
Abstract
The in vitro opsonic activity of a native, pH 4.25 immunoglobulin G preparation modified for intravenous use (IGIV pH 4.25) was compared with the activities of a standard reduced and alkylated, pH 6.8 preparation (IGIV-R/A pH 6.8) and a reduced and alkylated, pH 5.25 preparation (IGIV-R/A pH 5.25) against a variety of common bacterial pathogens. In most instances the opsonic titers of IGIV pH 4.25 equaled or exceeded that of IGIV-R/A pH 6.8; IGIV-R/A pH 5.25 usually had an intermediate level of activity. The protective activity of IGIV pH 4.25 against Escherichia coli in a neonatal rat model was also greater than that of IGIV-R/A pH 6.8. Thus, the functional activity of the new IGIV pH 4.25 apparently equals or exceeds that of standard reduced and alkylated preparations.
Similar articles
-
Comparative opsonic activity of intravenous gamma globulin preparations for common bacterial pathogens.Am J Med. 1984 Mar 30;76(3A):61-6. doi: 10.1016/0002-9343(84)90321-8. Am J Med. 1984. PMID: 6424458
-
Mechanisms of bacterial opsonization by immune globulin intravenous: correlation of complement consumption with opsonic activity and protective efficacy.J Infect Dis. 1989 Apr;159(4):701-7. doi: 10.1093/infdis/159.4.701. J Infect Dis. 1989. PMID: 2494269
-
Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin compared with sandoglobulin.Clin Exp Immunol. 1989 Apr;76(1):8-12. Clin Exp Immunol. 1989. PMID: 2500275 Free PMC article.
-
The role of specific antibody in neonatal bacterial infections: an overview.Pediatr Infect Dis. 1986 May-Jun;5(3 Suppl):S164-7. Pediatr Infect Dis. 1986. PMID: 3520499 Review.
-
Overview of the biochemistry and safety of a new native intravenous gamma globulin, IGIV, pH 4.25.Am J Med. 1987 Oct 23;83(4A):46-51. doi: 10.1016/0002-9343(87)90550-x. Am J Med. 1987. PMID: 3118708 Review.
Cited by
-
Supplemental immunoglobulin (ivIgG) treatment in 163 patients with sepsis and septic shock--an observational study as a prerequisite for placebo-controlled clinical trials.Infection. 1991 Jul-Aug;19(4):216-27. doi: 10.1007/BF01644948. Infection. 1991. PMID: 1917032 Clinical Trial.
-
Immunoglobulin therapy for neonatal sepsis: an overview of animal and clinical studies.J Clin Immunol. 1990 Nov;10(6 Suppl):40S-46S. doi: 10.1007/BF00918690. J Clin Immunol. 1990. PMID: 2081788 Review.
-
Role of neutrophil receptors in opsonophagocytosis of coagulase-negative staphylococci.Infect Immun. 1991 Aug;59(8):2573-8. doi: 10.1128/iai.59.8.2573-2578.1991. Infect Immun. 1991. PMID: 1855977 Free PMC article.
-
The potential use of monoclonal antibodies as therapeutic modalities in neonatal infection.Clin Rev Allergy. 1992 Spring-Summer;10(1-2):29-38. doi: 10.1007/978-1-4612-0417-6_3. Clin Rev Allergy. 1992. PMID: 1606522 No abstract available.
-
Overview of pharmacological treatment of Kawasaki disease.Drugs. 1999 Nov;58(5):813-22. doi: 10.2165/00003495-199958050-00004. Drugs. 1999. PMID: 10595862 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical